Arcturus Therapeutics Holdings Overview
Arcturus Therapeutics Holdings Target Price
Analysts' 12-month price predictions for ARCT.
Share Price
$12.53
Average Target Price
$40.00
219.2% upside
219.2% upside2 analysts in the last 4 months
High: $48 | Low: $32
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-05-28 | ScotiabankGreg Harrison | $32 | 155.4% upside |  |
| 2025-03-10 | BTIGThomas Shrader | $48 | 283.1% upside | |
| 2024-11-11 | Canaccord GenuityWhitney Ijem | $10.58 |  15.6% downside | |
| 2024-08-06 | Canaccord GenuityWhitney Ijem | $10.3 | 17.8% downside | |
| 2024-07-02 | H.C. WainwrightEd Arce | $8.58 | 31.5% downside | |
| 2024-05-31 | Piper SandlerYasmeen Rahimi | $20.02 | 59.8% upside | |
| 2024-05-10 | Canaccord GenuityWhitney Ijem | $12.3 | 1.8% downside | |
| 2024-03-19 | LaidlawYale Jen | $11.3 | 9.8% downside | |
| 2022-11-02 | BarclaysGena Wang | $25 | 99.5% upside | |
| 2022-05-11 | Goldman Sachs | $14 | 11.7% upside | |
| 2021-11-09 | Goldman SachsMadhu Kumar | $30 | 139.4% upside | |